Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine

@article{Zacny1990ToleranceAC,
  title={Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine},
  author={J. Zacny and R. M. Virus and W. Woolverton},
  journal={Pharmacology Biochemistry and Behavior},
  year={1990},
  volume={35},
  pages={637-642}
}
  • J. Zacny, R. M. Virus, W. Woolverton
  • Published 1990
  • Psychology, Medicine
  • Pharmacology Biochemistry and Behavior
    • The effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) (0.62-20.0 mg/kg), (+)-methamphetamine (MA) (0.62-5.0 mg/kg) and (+/-)-3,4-methylenedioxyamphetamine (MDA) (0.62-5.0 mg/kg) on milk intake in rats were determined before and during a period of repeated daily administration of MDMA. Experimental sessions consisted of 15-min access to a sweetened milk solution each day, 5 days a week. After initial determination of the effects of MDMA, MA and MDA on milk intake, rats were injected daily… CONTINUE READING
    View on Elsevier
    maps.org
    15 Citations
    Highly Influential Citations
    1
    Background Citations
    4
    Results Citations
    2

    Figures, Tables, and Topics from this paper

    Figures and Tables

    Explore Further: Topics Discussed in This Paper

    15 Citations
    Citation Type

    Citation Type

    Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges
    • 59
    Repeated Adolescent 3,4-Methylenedioxymethamphetamine (MDMA) Exposure in Rats Attenuates the Effects of a Subsequent Challenge with MDMA or a 5-Hydroxytryptamine1A Receptor Agonist
    • 45
    • PDF
    Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (+/-)-MDMA neurotoxicity: protection by fluoxetine.
    • 12
    Effect of once weekly treatment with 3,4-methylenedioxymethamphetamine on schedule-controlled behavior in rats.
    • 6
    • Highly Influenced
    • PDF
    MDMA and memory: the acute and chronic effects of MDMA in pigeons performing under a delayed-matching-to-sample procedure
    • 23
    Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
    • A. Parrott
    • Psychology, Medicine
    • Journal of psychopharmacology
    • 2005
    • 195
    • PDF
    The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA)
    • 143
    Adolescent MDMA Exposure Diminishes the Physiological, Behavioral, and Neurotoxic Consequences of a Subsequent Methamphetamine Binge
    • PDF
    MDMA effects consistent across laboratories
    • 34
    MDMA (“ecstasy”) abuse as an example of dopamine neuroplasticity
    • S. Schenk
    • Psychology, Medicine
    • Neuroscience & Biobehavioral Reviews
    • 2011
    • 36

    References

    SHOWING 1-10 OF 23 REFERENCES
    Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.
    • 49
    The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.
    • 54
    The effect of MDMA (“Ecstasy”) and its optical isomers on schedule-controlled responding in mice
    • 35
    • PDF
    Discriminative stimulus properties of MDA analogs.
    • 88
    Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    • 192
    Discriminative profile of MDMA
    • M. Schechter
    • Psychology, Medicine
    • Pharmacology Biochemistry and Behavior
    • 1986
    • 62
    Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.
    • 137
    In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain.
    • 286
    Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys
    • 52
    Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.
    • 147
    • PDF